Prof Therese Kinsella, founder and chief executive of Atxa Therapeutics. Photograph: Vincent Hoban

UCD spinout drug company Atxa Therapeutics, which is developing novel therapies that tackle a deadly heart condition, is seeking to raise $30 million (...)

John Given, who has joined corporate law firm Philip Lee as a senior partner in its mergers and acquisitions team.

John Given, the former Elan general counsel and founding chairman of Malin Corporation, has joined Dublin corporate law firm Philip Lee as a senior pa(...)

Alex Hobbs, chairman and Sarah-Jane Larkin, director general, Irish Venture Capital Association. The IVCA has urged the Government to act following weak investment figures. Photograph: Colm Mahady/Fennell Photography

Venture capital funding into Irish tech firms fell by 9 per cent in the first half of 2018, the first time that the funding has fallen since 2011. Th(...)

Dr Albert Agro, chief executive of Sublimity Therapeutics.

Irish-founded pharma company Sublimity Therapeutics, which closed a $64 million (€55 million) round in May, has said it will need to raise “significan(...)

 Sublimity’s chief technology officer Ivan Coulter

Irish-founded pharma company Sublimity Therapeutics is considering a potential flotation as it looks to get its flagship solution to market within the(...)

 Ivan Coulter, chief executive of Sigmoid Pharma.

Irish pharma company Sublimity Therapeutics (formerly Sigmoid Pharma), has closed a $64 million (€54.7 million) financing round to fund the developmen(...)